Infliximab Therapy for Pediatric Crohn Disease and Ulcerative Colitis
Fig. 33.1 Design of the REACH study in pediatric Crohn disease Post hoc analyses of the REACH study evaluated the effect of infliximab in children with perianal CD. Seventy percent…